Literature DB >> 9632179

Risks of surgical management for cavernous malformations of the nervous system.

S Amin-Hanjani1, C S Ogilvy, R G Ojemann, R M Crowell.   

Abstract

OBJECTIVE: As more information evolves regarding the natural history of cavernous malformations (CMs), the risks of operative intervention must be balanced against nonoperative management. In an attempt to better delineate the surgical risks for operable CMs, we undertook a retrospective analysis of 94 patients with 97 CMs surgically excised at the Massachusetts General Hospital.
METHODS: Data regarding surgical complications and outcome measures, including neurological status and seizure outcome, were analyzed.
RESULTS: The incidence of transient neurological morbidity was 20.6%, but only 4 of the 97 operations (4.1%) resulted in persistent disabling neurological complications and 2 (2.1 %) in nondisabling deficits. There was no operative mortality. Brain stem lesions (n=14) were associated with the highest incidence of neurological complications, both transient and persistent (odds ratio, 4.8; 95% confidence interval, 1.5-15.7). The overall neurological outcome was excellent or good in 89.7% of all lesions: 96.8% of lobar CMs (n=63), 64.2% of brain stem CMs (n=14), 87.5% of cerebellar CMs (n=8), 100% of cranial nerve CMs (n=4), and 75% of spinal cord CMs (n=8). Patients with brain stem and spinal cord CMs were in poorer preoperative neurological condition than were patients with CMs in other locations and therefore had a significantly reduced level of function after surgery (P < 0.01). There was improvement in 35.7% of the patients with brain stem lesions and 62.5% of the patients with spinal cord lesions after surgery. In the 38 patients presenting with seizures, 97% were seizure-free after surgery.
CONCLUSION: The risks of operative management of CMs varies based on location. When evaluating patients with operable CMs for surgery, the incidence of complications as well as final neurological outcome should be carefully weighed against the existing knowledge of the natural history of lesions managed expectantly.

Entities:  

Mesh:

Year:  1998        PMID: 9632179     DOI: 10.1097/00006123-199806000-00007

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

Review 1.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

2.  Diagnosis and treatment of vascular malformations of the brain.

Authors:  Bradley A Gross; Rose Du
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

3.  Stand-alone 3D-ultrasound navigation after failure of conventional image guidance for deep-seated lesions.

Authors:  Dorothea Miller; Ludwig Benes; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2011-05-17       Impact factor: 3.042

Review 4.  Tailored Treatment Options for Cerebral Cavernous Malformations.

Authors:  Jessa E Hoffman; Blake Wittenberg; Brent Morel; Zach Folzenlogen; David Case; Christopher Roark; Samy Youssef; Joshua Seinfeld
Journal:  J Pers Med       Date:  2022-05-20

5.  Pineal cavernous malformations: report of two cases.

Authors:  Dong-Seok Kim; Kyu-Won Shim; Tae-Gon Kim; Jong-Hee Chang; Yong-Gou Park; Joong-Uhn Choi
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

6.  Functional and topographical considerations in the surgical management of cerebral vascular malformations.

Authors:  G Mohr; D Tampieri; D Klein; L Soualmi
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

Review 7.  Management of cerebral cavernous malformations: from diagnosis to treatment.

Authors:  Nikolaos Mouchtouris; Nohra Chalouhi; Ameet Chitale; Robert M Starke; Stavropoula I Tjoumakaris; Robert H Rosenwasser; Pascal M Jabbour
Journal:  ScientificWorldJournal       Date:  2015-01-05

8.  Outcome after surgical or conservative management of cerebral cavernous malformations.

Authors:  Fiona Moultrie; Margaret A Horne; Colin B Josephson; Julie M Hall; Carl E Counsell; Jo J Bhattacharya; Vakis Papanastassiou; Robin J Sellar; Charles P Warlow; Gordon D Murray; Rustam Al-Shahi Salman
Journal:  Neurology       Date:  2014-07-03       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.